Asgct annual meetings 2022-24: travel awards and underrepresented minority travel awards - american society of gene and cell therapy PA-21-151 project summary this application by the american…
Ended Project Grant Awarded Last action
- Award ID
- R13TR004216
- Recipient
-
The American Society Of Gene & Cell Therapy UEI DFTKQFFUPZX8
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $75,000
Award facts
- Assistance listing
- 93.350 National Center for Advancing Translational Sciences
- Completion date
- Place of performance
- Wisconsin, USA
Award details come from USAspending.gov.
Description
Asgct annual meetings 2022-24: travel awards and underrepresented minority travel awards - american society of gene and cell therapy PA-21-151 project summary this application by the american society of gene and cell therapy (asgct) requests $15,000 for 10 travels award and 20 underrepresented minority travel awards ($500 per award) for students and post-doctoral fellows to attend the asgct annual meetings in 2022, 2023, and 2024-for a total of $45,000 and 90 travel awards. To determine awards, asgct run a report from our abstract presenter database that pools abstract applicants who are students or post-doctoral fellows. Those with the top 15 scoring abstracts receive an excellence in research award (not supported by this grant), and those scoring over 3.5 receive a $500 travel award (such as those supported by this grant). Then, remaining applicants who identify as underrepresented individuals are ranked by score, and the top 20 are given travel awards (also to be supported by this grant). Asgct abides strictly by the NIH's definition of underrepresentation populations in selecting awardees. Asgct's mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. This project bolsters our mission by supporting early-career professional to travel to our annual meetings to gain exposure for their research, thereby advancing knowledge and spurning professional development that will better position those early-career professionals to make discoveries and produce clinical applications in the future.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $15,000 | |
| Amendment | $15,000 | |
| Amendment | $15,000 | |
| Amendment | $15,000 | |
| Original award | $15,000 |
Quick answers
Who received award R13TR004216?
R13TR004216 was awarded to The American Society Of Gene & Cell Therapy by National Center for Advancing Translational Sciences (National Institutes of Health) on May 1, 2022.
How much is award R13TR004216 worth?
$75,000 has been obligated on R13TR004216.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award